Article
In Situ Single Cell Proteomics Reveals Circulating Tumor Cell Heterogeneity during Treatment
6 Jul 2021
Abstract excerpt
Cancer is a dynamic disease with heterogenic molecular signatures and constantly evolves during the course of the disease. Single cell proteomic analysis could offer a suitable pathway to monitor cancer cell heterogeneity and deliver critical information for the diagnosis, recurrence, and drug-resistant mechanisms in cancer. Current standard techniques for proteomic analysis such as ELISA, mass spectrometry, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
